h.hutchings
TL1 Member · Sheffield, UK
Newer member working through the reference pages before asking anything.
Joined 27 March 2025 · last posted 1mo
24Posts here
0Topics
0Solutions
172Likes received
138Likes given
10Badges
79Days visited
593Posts read
Stated areas
Recent activity
Full stream-
Naming conventions for research peptides and the confusion they cause Replied, post #19 · Compounds › Other compounds · 22 Jun 2026 · 12 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #44 · Analytics › Method validation · 6 Jun 2026 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #49 · Compounds › Semaglutide · 3 Jun 2026 · 9 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Area percent versus weight percent: the confusion that causes most arguments Replied, post #9 · Analytics › HPLC & UHPLC · 12 May 2026 · 4 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Journal club: is percentage weight change the right endpoint? Replied, post #110 · Evidence › Journal club · 27 Apr 2026 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Grapefruit: why this class is not the class that cares Replied, post #125 · Practice › Interactions · 6 Apr 2026 · 0 likes Picking up post #122: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Second pass at: Submitting a sample: the process end to end Replied, post #14 · Sourcing › Independent verification · 16 Mar 2026 · 15 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Journal club: PIONEER 6 as a safety trial Replied, post #15 · Evidence › Journal club · 26 Jan 2026 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
DXA precision and the least significant change for lean mass Replied, post #42 · Outcomes › Body composition · 4 Dec 2025 · 4 likes Worth separating two things that post #38 runs together. Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent.…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #96 · Practice › Administration · 6 Oct 2025 · 2 likes On post #92 — agreed on the reasoning, with one qualification. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in…
-
Documentation that materially improves an appeal's chances Replied, post #15 · Access › Insurance & coverage · 1 Oct 2025 · 0 likes This follows post #12 rather than contradicting it. Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by…
-
When to stop reading forums, including this one Replied, post #28 · Wellbeing › Mental health · 22 Sep 2025 · 28 likes Picking up post #25: that is the part I would want checked first. Body image and weight loss: large weight loss changes a person's relationship with their body in ways…